In furtherance to our intimation dated 08th October, 2025 and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors, in its meeting held on 13th October 2025 (5:30 PM to 7:00 PM), approved the unaudited financial results for the quarter and half year ended 30th September 2025. For Q2 FY26, the company reported a loss of ₹2.86 lakhs on total income of ₹7.30 lakhs, with no revenue from operations, and a negative EPS of ₹0.40. For the half year ended 30th September 2025, total comprehensive income stood at ₹3.83 lakhs. The balance sheet shows a sharp increase in total assets from ₹371.82 lakhs (March 2025) to ₹2,720.37 lakhs (September 2025), driven mainly by a major capital raise. Equity share capital rose from ₹50 lakhs to ₹267.50 lakhs, with additional share application money of ₹195.25 lakhs and ₹940.75 lakhs received against share warrants. The cash flow statement shows ₹2,680.25 lakhs raised through financing activities (preferential issue and warrants), partially offset by a ₹4,564.58 lakhs operating cash outflow mainly due to loans given and working capital changes. The limited review was conducted by N.K. Jalan & Co., Chartered Accountants.
The quarterly loss and weak operating revenue are negatives for short-term sentiment, but the substantial capital infusion via preferential issue and share warrants significantly strengthens the company's equity base, suggesting future expansion or business plans. Shareholders should watch for clarity on how the raised funds will be deployed.